The Journal of Heart and Lung Transplantation
Volume 29, Issue 7 , Pages 717-727 , July 2010

International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy—2010

References 

  1. Schmauss D, Weis M. Cardiac allograft vasculopathy: recent developments. Circulation. 2008;117:2131–2141
  2. Mehra MR. Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy. Am J Transplant. 2006;6:1248–1256
  3. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005;24:1710–1720
  4. Hirohata A, Nakamura M, Waseda K, et al. Changes in coronary anatomy and physiology after heart transplantation. Am J Cardiol. 2007;99:1603–1607
  5. Keogh AM, Valantine HA, Hunt SA, et al. Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation. J Heart Lung Transplant. 1992;11:892–901
  6. Gao SZ, Alderman EL, Schroeder JS, et al. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol. 1988;12:334–340
  7. Costanzo M, Naftel D, Pritzker M, et al. Heart transplant coronary artery disease detected by coronary angiography: A multi-institutional study of preoperative donor and recipient risk factors. J Heart Lung Transplant. 1998;17:744–753
  8. Gao SZ, Hunt SA, Schroeder JS, et al. Early development of accelerated graft coronary artery disease: risk factors and course. J Am Coll Cardiol. 1996;28:673–679
  9. Stork S, Behr TM, Birk M, et al. Assessment of cardiac allograft vasculopathy late after heart transplantation: when is coronary angiography necessary?. J Heart Lung Transplant. 2006;25:1103–1108
  10. Itagaki BK, Kobashigawa JA, Wu GW, et al. Widespread fibrosis of myocardial and adjacent tissues causing restrictive cardiac physiology in patients needing re-do heart transplant. J Heart Lung Transplant. 2007;26:S138
  11. Mehra MR, Ventura HO, Stapleton DD, Smart FW. The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift. J Heart Lung Transplant. 1995;14:S207–S211
  12. Tuzcu EM, Kapadia SR, Sachar R, et al. Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. J Am Coll Cardiol. 2005;45:1538–1542
  13. Kobashigawa JA, Tobis JM, Starling RC, et al. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. J Am Coll Cardiol. 2005;45:1532–1537
  14. Ramasubbu K, Schoenhagen P, Balghith MA, et al. Repeated intravascular ultrasound imaging in cardiac transplant recipients does not accelerate transplant coronary artery disease. J Am Coll Cardiol. 2003;41:1739–1743
  15. Tsutsui H, Ziada KM, Schoenhagen P, et al. Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: results from a 5-year serial intravascular ultrasound study. Circulation. 2001;104:653–657
  16. Kapadia SR, Ziada KM, L'Allier PL, et al. Intravascular ultrasound imaging after cardiac transplantation: advantage of multi-vessel imaging. J Heart Lung Transplant. 2000;19:167–172
  17. Mehra MR, Benza R, Deng MC, Russell S, Webber S. Surrogate markers for late cardiac allograft survival. Am J Transplant. 2004;4:1184–1191
  18. Pries AR, Habazettl H, Ambrosio G, et al. A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings. Cardiovasc Res. 2008;80:165–174
  19. Kubrich M, Petrakopoulou P, Kofler S, et al. Impact of coronary endothelial dysfunction on adverse long-term outcome after heart transplantation. Transplantation. 2008;85:1580–1587
  20. Fearon WF, Balsam LB, Farouque HM, et al. Novel index for invasively assessing the coronary microcirculation. Circulation. 2003;107:3129–3132
  21. Potluri SP, Mehra MR, Uber PA, Park MH, Scott RL, Ventura HO. Relationship among epicardial coronary disease, tissue myocardial perfusion, and survival in heart transplantation. J Heart Lung Transplant. 2005;24:1019–1025
  22. Hollenberg SM, Tamburro P, Klein LW, et al. Discordant epicardial and microvascular endothelial responses in heart transplant recipients early after transplantation. J Heart Lung Transplant. 1998;17:487–494
  23. Hiemann NE, Wellnhofer E, Knosalla C, et al. Prognostic impact of microvasculopathy on survival after heart transplantation—evidence from 9,713 endomyocardial biopsies. Circulation. 2007;116:1274–1282
  24. Escaned J, Flores A, Garcia-Pavia P, et al. Assessment of microcirculatory remodeling with intracoronary flow velocity and pressure measurements (Validation with endomyocardial sampling in cardiac allografts). Circulation. 2009;120:1561–1568
  25. Ciliberto GR, Ruffini L, Mangiavacchi M, et al. Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of long-term prognosis after heart transplantation. Eur Heart J. 2001;22:964–971
  26. Wu YW, Yen RF, Lee CM, et al. Diagnostic and prognostic value of dobutamine thallium-201 single-photon emission computed tomography after heart transplantation. J Heart Lung Transplant. 2005;24:544–550
  27. Akosah KO, Mc Daniel S, Hanrahan JS, Mohanty PK. Dobutamine stress echocardiography early after heart transplantation predicts development of allograft coronary artery disease and outcome. J Am Coll Cardiol. 1998;31:1607–1614
  28. Spes CH, Klauss V, Mudra H, et al. Diagnostic and prognostic value of serial dobutamine stress echocardiography for non-invasive assessment of cardiac allograft vasculopathy: a comparison with coronary angiography and intravascular ultrasound. Circulation. 1999;100:509–515
  29. Derumeaux G, Redonnet M, Mouton-Schleifer D, et al. Dobutamine stress echocardiography in orthotopic heart transplantation. J Am Coll Cardiol. 1995;25:1665–1672
  30. Sigurdsson G, Carrascosa P, Yamani MH, et al. Detection of transplant coronary artery disease using multidetector computed tomography with adaptive multisegment reconstruction. J Am Coll Cardiol. 2006;48:772–778
  31. Iyengar S, Feldman DS, Cooke GE, Leier CV, Raman SV. Detection of coronary artery disease in orthotopic heart transplant recipients with 64-detector row computed tomography angiography. J Heart Lung Transplant. 2006;25:1363–1366
  32. Romeo G, Houyel L, Angel CY, Brenot P, Riou JY, Paul JF. Coronary stenosis detection by 16-slice computed tomography in heart transplant patients: comparison with conventional angiography and impact on clinical management. J Am Coll Cardiol. 2005;45:1826–1831
  33. Gregory SA, Ferencik M, Achenbach S, et al. Comparison of 64-slice multidetector computed tomographic coronary angiography to coronary angiography with intravascular ultrasound for the detection of transplant vasculopathy. Am J Cardiol. 2006;98:877–884
  34. Schepis T, Achenbach S, Weyand M, et al. Comparison of dual source computed tomography versus intravascular ultrasound for evaluation of coronary arteries at least one year after cardiac transplantation. Am J Cardiol. 2009;104:1351–1356
  35. Yamani MH, Tuzcu EM, Starling RC, et al. Computerized scoring of histopathology for predicting coronary vasculopathy, validated by intravascular ultrasound. J Heart Lung Transplant. 2002;21:850–859
  36. Palmer DC, Tsai CC, Roodman ST, et al. Heart graft arteriosclerosis (An ominous finding on endomyocardial biopsy). Transplantation. 1985;39:385–388
  37. Pardo Mindan FJ, Panizo A, Lozano MD, Herreros J, Mejia S. Role of endomyocardial biopsy in the diagnosis of chronic rejection in human heart transplantation. Clin Transplant. 1997;11:426–431
  38. Neish AS, Loh E, Schoen FJ. Myocardial changes in cardiac transplant-associated coronary arteriosclerosis: potential for timely diagnosis. J Am Coll Cardiol. 1992;19:586–592
  39. Stary HC, McMillan GC. Kinetics of cellular proliferation in experimental atherosclerosis. Arch Pathol. 1970;89:173–183
  40. Stary HC, Strong JP. The fine structure of non-atherosclerotic intimal thickening, of developing and of regressing atherosclerotic lesions at the bifurcation of the left coronary artery. Adv Exp Med Biol. 1976;67:89–108
  41. Stary HC. The origin in atherosclerotic lesions of extracellular lipid and debris and their elimination during regression (International symposium: state of prevention and therapy in Junan atherosclerosis and animal models). In: 1977;p. 39–53
  42. Stary HC, Malinov MR. Ultrastructure of experimental coronary artery atherosclerosis in cynomolgus macaques. Atherosclerosis. 1982;43:151–175
  43. Amenta PS. Elias-Pauly's histology & human micro-anatomy. In: 5th ed. New York: John Wiley and Sons; 1987;p. 198–200
  44. Gross L, Epstein EZ, Kugel MA. Histology of the coronary arteries and their branches in the human heart. Am M Pathol. 1934;10:253–274
  45. Dock W. The predilection of atherosclerosis for the coronary arteries. JAMA. 1946;131:875–878
  46. Velican C, Velican D. Intimal thickening in developing coronary arteries and its relevance to atherosclerotic involvement. Atherosclerosis. 1976;23:345–355
  47. Velican D, Velican C. Study of fibrous plaques occurring in the coronary arteries of children. Atherosclerosis. 1979;33:201–215
  48. Velican C, Velican D. The precursors of coronary atherosclerotic plaques in subjects up to 40 years old. Atherosclerosis. 1980;37:33–46
  49. Rahlf G. Intramyocardial microarteriopathy. Virchows Arch Path Anat Histol. 1980;388:289–311
  50. Whelan NL, Subramanian R, Jin J, Keith IM. Intramyocardial arterial cushions of coronary vessels in animals and humans: morphology, occurrence and relation to heart disease. J Vasc Res. 1996;33:209–224
  51. Houser S, Muniappan A, Allan J, Sachs D, Madsen JC. Cardiac allograft vasculopathy: real or a normal morphologic variant?. J Heart Lung Transplant. 2007;26:167–173
  52. Tan CD, Baldwin WM, Rodriguez ER. Update on cardiac transplantation pathology. Arch Pathol Lab Med. 2007;131:1169–1191
  53. Rose M. De novo production of antibodies after heart or lung transplantation should be regarded as an early warning system. J Heart Lung Transplant. 2004;23:385–395
  54. Rose M. Non-HLA antibodies and the role of the autoimmune response in transplant rejection. Curr Opin Organ Transplant. 2006;11:439–443
  55. Mehra MR, Uber PA, Uber WE, Scott RL, Park MH. Allosensitization in heart transplantation: implications and management strategies. Curr Opin Cardiol. 2003;18:153–158
  56. Vasilescu ER, Ho EK, de la Torre L, et al. Anti-HLA antibodies in heart transplantation. Transpl Immunol. 2004;12:177–183
  57. Tambur A, Pamboukian S, Costanzo M, et al. The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome. Transplantation. 2005;80:1019–1025
  58. McKay M, Pinney S, Gorwara S, et al. Anti-human leukocyte antigen antibodies are associated with restenosis after percutaneous coronary intervention for cardiac allograft vasculopathy. Transplantation. 2005;79:1581–1587
  59. Mahesh B, Leong HS, McCormack A, Sarathchandra P, Holder A, Rose ML. Autoantibodies to vimentin cause accelerated rejection of cardiac allografts. Am J Pathol. 2007;170:1415–1427
  60. Kaczmarek I, Deutsch MA, Kauke T, et al. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant. Exp Clin Transplant. 2008;6:229–235
  61. Poggio ED, Roddy M, Riley J, et al. Analysis of immune markers in human cardiac allograft recipients and association with coronary artery vasculopathy. J Heart Lung Transplant. 2005;24:1606–1613
  62. Mehra MR. The emergence of genomic and proteomic biomarkers in heart transplantation. J Heart Lung Transplant. 2005;24(7 suppl):S213–S218
  63. Ventura HO, Mehra MR. C-Reactive protein and cardiac allograft vasculopathy (Is inflammation the critical link?). J Am Coll Cardiol. 2003;42:483–485
  64. Mehra MR, Uber PA, Walther D, et al. Gene expression profiles and B-type natriuretic peptide elevation in heart transplantation: more than a hemodynamic marker. Circulation. 2006;114(1 suppl):I21–I26
  65. Mehra MR, Uber PA, Potluri S, Ventura HO, Scott RL, Park MH. Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation. Am J Cardiol. 2004;94:454–458
  66. Mehra MR, Uber PA, Park MH, et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol. 2004;43:1590–1595
  67. Mehra MR, Kobashigawa JA, Deng MC, et al. ; CARGO Investigators (Transcriptional signals of T-cell and corticosteroid-sensitive genes are associated with future acute cellular rejection in cardiac allografts). J Heart Lung Transplant. 2007;26:1255–1263
  68. Mehra MR, Kobashigawa JA, Deng MC, et al. ; CARGO Investigators (Clinical implications and longitudinal alteration of peripheral blood transcriptional signals indicative of future cardiac allograft rejection). J Heart Lung Transplant. 2008;27:297–301
  69. Kirk R, Edwards LB, Aurora P, et al. Registry of the International Society for Heart and Lung Transplantation: eleventh official pediatric heart transplantation report—2008. J Heart Lung Transplant. 2008;27:970–977
  70. Pahl E, Naftel DC, Kuhn M, et al. The impact and outcome of transplant coronary artery disease in a pediatric population: a 9-year multi-institutional study. J Heart Lung Transplant. 2005;24:645–651
  71. Hathout E, Beeson L, Kuhn M, et al. Cardiac allograft vasculopathy in pediatric heart transplant recipients. Transpl Int. 2006;19:184–189
  72. Ross M, Kouretas P, Gamberg P, et al. Ten and 20-year survivors of pediatric orthotopic heart transplantation. J Heart Lung Transplant. 2006;25:261–270
  73. Costello JM, Wax DF, Binns HJ, Backer CJ, Mavroudis C, Pahl E. A comparison of intravascular ultrasound with coronary angiography for evaluation of transplant coronary disease in pediatric heart transplant recipients. J Heart Lung Transplant. 2003;22:44–49
  74. Dent CL, Canter CE, Hirsch R, et al. Transplant coronary artery disease in pediatric heart transplant recipients. J Heart Lung Transplant. 2000;19:240–248
  75. Hiemann NE, Wellnhofer E, Abdul-Khaliq H, Hetzer R, Meyer R. Epicardial and microvascular graft vessel disease in children. Acta Paediatr. 2004;93(suppl):70–74
  76. Kuhn MA, Jutzy KR, Deming DD, et al. The medium-term findings in coronary arteries by intravascular ultrasound in infants and children after heart transplantation. J Am Coll Cardiol. 2000;36:250–254
  77. Mulla NF, Johnston JK, Vander Dussen L, et al. Late rejection is a predictor of transplant coronary artery disease in children. J Am Coll Cardiol. 2001;37:243–250
  78. Razzouk AJ, Chinnock RE, Dearani JA, et al. Cardiac retransplantation for graft vasculopathy in children: should we continue to do it?. Arch Surg. 1998;133:881–885
  79. Nicolas RT, Kort HW, Balzer DT, et al. Surveillance for transplant coronary artery disease in infant, child and adolescent heart transplant recipients: an intravascular ultrasound study. J Heart Lung Transplant. 2006;25:921–927
  80. Larsen RL, Applegate PM, Dyar DA, et al. Dobutamine stress echocardiography for assessing coronary artery disease after transplantation in children. J Am Coll Cardiol. 1998;32:515–520
  81. Pahl E, Crawford SE, Swenson JM, et al. Dobutamine stress echocardiography: experience in pediatric heart transplant recipients. J Heart Lung Transplant. 1999;18:725–732
  82. Di Filippo S, Semiond B, Roriz R, et al. Non-invasive detection of coronary artery disease by dobutamine-stress echocardiography in children after heart transplantation. J Heart Lung Transplant. 2003;22:876–882
  83. Dipchand AI, Bharat W, Manlhiot C, Safi M, Lobach NE, McCrindle BW. A prospective study of dobutamine stress echocardiography for the assessment of cardiac allograft vasculopathy in pediatric heart transplant recipients. Pediatr Transplant. 2008;12:570–576
  84. Gagliardi MG, Crea F, Polletta B, et al. Coronary microvascular endothelial dysfunction in transplanted children. Eur Heart J. 2001;22:254–260
  85. Schubert S, Abdul-Khaliq H, Wellnhofer E, et al. Coronary flow reserve measurement detects transplant coronary artery disease in pediatric heart transplant patients. J Heart Lung Transplant. 2008;27:514–521
  86. Fyfe DA, Ketchum D, Lewis R, et al. Tissue Doppler imaging detects severely abnormal myocardial velocities that identify children with pre-terminal cardiac graft failure after heart transplantation. J Heart Lung Transplant. 2006;25:510–517
  87. Bae K, Hong C, Takahashi N, et al. Multi-detector row computed tomographic angiography in pediatric heart transplant recipients: initial observations. Transplantation. 2004;599–602
  88. Dipchand AI, Manlhiot C, Russell JL, Gurofsky R, Kantor PF, McCrindle BW. Exercise capacity improves with time in pediatric heart transplant recipients. J Heart Lung Transplant. 2009;28:585–590

PII: S1053-2498(10)00312-8

doi: 10.1016/j.healun.2010.05.017

The Journal of Heart and Lung Transplantation
Volume 29, Issue 7 , Pages 717-727 , July 2010

Article Tools

* Image Usage & Resolution